Effects of Preoperative Flavonoid Supplementation on Different Organ Functions in Rats

Effects of Preoperative Flavonoid Supplementation on Different Organ Functions in Rats

van Hoorn, Danny E C

ABSTRACT. Background: Previously it has been reported that preoperative feeding preserves heart function in rats after intestinal ischemia-reperfusion. To further improve postoperative organ function, bioactive nutrition compounds were selected in vitro against the xanthine oxidase radical cascade, an enzyme suggested to play a key role in the induction of single- or multiple-organ dysfunction. Methods: FIavonoids were selected in vitro for their capacity to (1) inhibit xanthine oxidase, (2) scavenge superoxide, and (3) scavenge peroxylradicals. The most bioactive flavonoids were added to the preoperative nutrition to study their effect on postintestinal ischemia-reperfusion organ function. Results: A combination of flavonoids selected on basis of effective flavonoid xanthine oxidase inhibition and superoxide scavenging resulted in increased superoxide scavenging. In vivo, the selected flavonoid mixture significantly lowered postischemic intestinal apoptosis and intestinal oxidative stress indicated by malondialdehyde concentration when compared with ischemia-reperfusion fasted and sham-fasted animals. Moreover, this flavonoid mixture significantly lowered plasma creatinine and urea concentration, both indicating a better postoperative kidney function. Furthermore, oxidative stress measured as this flavonoid mixture when compared with control significantly lowered plasma malondialdehyde concentration in fed rats. Conclusions: Coadministration of bioactive flavonoid mixture to preoperative nutrition, in contrast to fasting, attenuates ischemia-reperfusion injury by preserving kidney function in the rat and decreasing apoptosis in the intestine. (Journal of Parenteral and Enterai Nutrition 30:302308, 2006)

Fasting before surgery, the standard procedure in Western Europe and many other countries, alters the metabolic response to stress,1-5 leading to a catabolic state. There are several clinical and experimental studies suggesting that preoperative feeding or early postoperative enterai feeding reduces, among others, postoperative complications and lean body mass.6-14 Previously, it has been reported that preoperative nutrition in contrast to fasting preserved heart function.15

Although it has been reported that preoperative feeding can improve postoperative complications, such as insulin resistance, little is known about factors in feeding causing this observed effect.

Postischemically, increase of xanthine oxidase (XO) enzyme activity can be an important mediator of postoperative oxidative stress after reperfusion.16-20 Increased oxidative stress might lead to increased organ injury, which eventually can lead to single- or multiple-organ dysfunction (S/MOD).21,22 Recent literature also suggests that a group of naturally occurring compounds called flavonoids, abundant in fruits and plants, may be potent inhibitors of XO.23-27 Some of these compounds have been reported to inhibit inducible nitric oxide synthase (iNOS)28-30 and to be involved in the reduction of inflammation.31″33 Both iNOS and general inflammation have been reported to promote S (MOD). We hypothesized that supplementation of preoperative food with a selected flavonoid mixture inhibiting the XO cascade (Figure 1) further decreases ischemia reperfusion (IR)-induced S (MOD).

The combination of flavonoids with the highest in vitro capacity were tested for their in vivo effectiveness when added to preoperative nutrition in a rat model of intestinal IR, as previously described.34 Postoperative clinical organ function parameters such as plasma urea, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and creatinine were measured in both a preoperative fasted group, a preoperative fed group, and a group supplemented additionally with the selected flavonoids. Also, the lipid peroxidation production of malondialdehyde (MDA) as indicator of oxidative stress was measured in rat plasma and intestine.

MATERIAL AND METHODS

In Vitro Research

XO inhibition. XO (X1875, Sigma Aldrich, Zwijndrecht, NL) activity was measured as described previously.24 In short, uric acid production is measured calorimetrically at 295 nm at pH 7.8. The flavonoids (Indofine Chemical Company Inc, NY) were tested up to a maximum concentration of 40 µM. Inhibition was expressed as IC^sub 50^. Allopurinol was used a standard inhibitor to compare against the activity of the flavonoids.

Superoxide scavenging assay. The assay is based on the nitrate method, with a slight modification in the XO activity (2.42 mil instead of 1.45 mU). In this assay, vitamin C is used a control superoxide scavenger.

The peroxyl radical scavenging method. The oxygen radical capacity assay (ORCA) is based on the work done by Cao et al35 laboratory. In short, the assay compares the protective effect of compounds on the decay velocity of the fluorescent protein β-phycoerythrin (Sigma Aldrich) with the water-soluble vitamin E analog, Trolox (8 µmol/L; Sigma Aldrich). The reaction mix contained 50 µl 50 mmol/L phosphate buffered saline (PBS) pH 7.4, 50 µl 66.8 nmol/L β-phycoerythrin, and 10 µL sample (either in water or ethanol). The reaction was started by addition of 100 µl 64 mmol/L 2.2′-azobis(2-amidinopropane; AAPH, Wako Chemicals, DE) at 28°C, which forms peroxyl radicals upon decay. This reaction was allowed to proceed to completion. Data are expressed in Trolox equivalents (TE) on a molar basis in which a compound with TE >1 is considered to be positive.

In Vivo Research

Ethical committee. The animal ethical committee of the Free University Medical Center (Amsterdam, NL) approved the animal experiments according to the Declaration of Helsinki.

Surgical details. Intestinal IR was applied as previously described.34 In short, the surgery was started by performing a laparotomy, followed by clamping the superior mesenteric artery for 60 minutes, followed by a reperfusion period of 180 minutes.

Male Wistar rats (250-350 g; Harlan, NL) were acclimatized for 7 days upon arrival, followed by a 7-day period of measuring body weight and food intake (semisynthetic feeding) twice a day (Table I). Five days before surgery, animals were divided into 4 groups.

The first group (sham-fasted, ç = 7) was allowed ad libitum access to food and drinking water until 13 hours before surgery. After 13 hours, the food was removed and water remained ad libitum. The shamfasted group received only a laparotomy and did not undergo ischemia. The second group (n = 10), referred to as the IR-fasted group, received the same preoperative procedure as the sham-fasted group and in addition underwent clamping of the superior mesenteric artery (SMA) for 60 minutes, resulting in IR injury of the intestine. The third group (n = 9), referred to as the IR-fed group, was allowed ad libitum access to food and drinking water until 2 hours before surgery and underwent the same clamping as experienced by the rats in the IR-fasted group. The fourth group (n = 9) was treated similarly as the third group (n = 9). In addition, the fourth group was supplemented with selected flavonoids, starting 5 days before surgery (Table II). The mixture was comprised of 4 g of quercetin, 3 g of luteolin, 3 g of apigenin, 5 g of epicatechin, and 10 g of green tea extract (Flachsmann, 085.0942, DE) added to 15 kg of standard feeding (Arie Blok Diervoeders). Assuming a food intake of 15 g per day estimates a flavonoid mixture intake of 25 mg. All rats were killed at the end of the 180-minute reperfusion period or the equivalent period in animals not subjected to IR injury (Table I), as described previously.34 For analyses of intestinal apoptosis, untreated ad libitum-fed animals (n = 4) were used as control because histology suggested shortened villi in the fasted groups, which impaired histologie quantification on apoptosis between fasted and fed groups.

Oxidative stress assessment. MDA concentration in plasma and intestine was measured as previously described by high performance liquid chromatography (HPLC).34

Apoptosis. Apoptosis was measured using the TUNEL assay.

Samples. Blood with 2% 0.275 M Na EDTA was centrifuged at 2600 X g at 4°C for 20 minutes, and plasma was used to determine urea, aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate, creatinine, MDA. The organs were assessed for MDA concentration, as described previously.34

Statistics. ANOVA was used for statistical analysis of the data by using SPSS version 11.0. The data were tested for normality by the Kolmogorov-Smirnov and the Shapiro-Wilk tests. The data were also tested by Levene’s test of equality of error variance. The results are presented as means ± SEM unless indicated otherwise. As a post hoc test, the Student’s ß-test was used; p

RESULTS

In Vitro Experiments

First, the flavonoids (Figure 2) were selected on basis of their XO inhibition out of a pool of >30 flavonoids, as previously described.24 As can be seen in Table II, the 3 most active flavonoids found were quercetin, apigenin, and luteolin. second, a concentration range of flavonoids was tested for their superoxide scavenging capacity using XO as a radical producing system. Only those flavonoids that showed an IC^sub 50^ value lower than expected from direct XO inhibition were considered as positive. As can be seen in Table II, epicatechin and the green tea extract showed superoxide-scavenging properties that even exceeded the capacity of ascorbic acid. Third, as can be seen in Table II, all 4 pure compounds showed good peroxyl-scavenging properties and may therefore provide an additional protection against peroxyl radicals. Finally, whether the components could be combined was tested. Figure 3 shows that a flavonoid mixture of both the most effective XO inhibitors and superoxide scavengers provided an additive effect on decreasing the production of superoxide, suggesting components are still active when combined.

In Vivo Experiments

To test if our hypothesis implicating that preoperative feeding with selected in vitro XO cascade inhibiting flavonoids may decrease IR injury, 4 groups of rats were included (Table I). In short, group I was sham fasted and served as control. Group II was also fasted and additionally received IR and served as reference for post-IR injury when rats were fasted. The third and fourth groups were both allowed feed until the operation. The third group received a standard feeding and served as reference for post-IR injury when rats were preoperatively fed. The fourth group received an additional mixture of flavonoids selected for their in vitro XO cascade inhibition.

In order to establish whether intestinal ischemia did result in the induction of organ injury, several organinjury and organ-function parameters were measured, and the effects of preoperative feeding with addition of a selected flavonoid mixture on these parameters were assessed.

Plasma Parameters of Kidney Function

As reported earlier,34 the intestinal IR model used resulted in higher plasma concentration of urea and creatinine (Table III; p

Plasma Parameters of Liver Function and Lactic Acidosis

IR resulted in increased ALT and lactate (Table III; p

Intestinal Apoptosis and Oxidative Stress Assessment

Intestinal apoptosis of preoperatively fed rats was significantly higher than the intestines of control rats (p

Intestinal oxidative stress, as measured by tissue MDA levels, was significantly increased in preoperatively fasted group II. This negative effect of preoperative fasting was completely abolished in the flavonoidsupplemented group, which showed a significant decreased MDA concentration when compared with IR fasted animals (p

Systemic Parameters of Oxidative Stress

As can be seen in Figure 6, the flavonoid mixture significantly decreased total body oxidative stress expressed as plasma MDA concentration (p

DISCUSSION

During ischemia, the supply of oxygen and nutrients is severely diminished, especially in organs with a high-energy expenditure, which are rapidly forced to make energy (ATP) in a less efficient, anaerobic, manner.36″ This transition to anaerobic use of fuel initiates the XO cascade (Figure 1), starting with the increase of the ATP breakdown product, hypoxanthine (HX).36’39 This process is associated with an increase in lactate concentration and sodium influx in cells.40-44 A sustained period of ischemia may therefore lead to apoptosis or necrosis of 1 or more organs. To prevent organs from failure, the supply of oxygen has to be restored during a reperfusion period. Paradoxically, a reperfusion period can aggravate the effect of the ischemie period.19,23,24,45-47 This study focuses on the role of the XO cascade in this effect, according to reports on the importance of XO as an inducer of oxidative stress48 via conversion of xanthine dehydrogenase (XDH) to XO during intestinal IR, leading to increased oxidative stress by increased superoxide (Figure 1). This pathway in oxidative stress is emphasized by the increase of mRNA concentrations of both XO and XDH increase after ischemia.49 Also, XO can bind to a specific XO receptor present on endothelial cells,50 rendering it inaccessible to free radical scavengers such as superoxide dismutase. This increased production of superoxide may initiate a XO-induced radical cascade (Figure 2), leading to the production of many different reactive oxygen species (ROS). Therefore, the role for XO in IR induced damage is well acknowledged.18,19,26,47,49,51-58

Flavonoids were selected for their individual capacity to interfere at 3 levels with the initiation and prolongation of the XO induced radical cascade (Figure 1).1-5 As described in a previous study, flavonones, a subgroup in the flavonoid family, are effective xanthine inhibitors, being even superior in vitro to allopurinol.24 Because an increased XO activity results in an increased superoxide production (Figure 1), flavonoids were also selected for their superoxide scavenging capacity. A combination of the most effective XO inhibitors and superoxide scavengers (Figure 3) showed, in a concentration range that is achievable in plasma, an additional effect on superoxide scavenging.59-61 The most effective XO inhibitors and superoxide scavengers furthermore showed good peroxyl scavenging capacity and might therefore influence the XO radical producing systems in vivo at 3 multiple levels (Figure 2). We therefore selected these flavonoids for their possible effectiveness upon organ function improvement and biochemical parameters in vivo.

In the rat intestinal IR injury model, the plasma urea has frequently been reported to be increased during IR. This has been confirmed in the present study in which the IR fasted animals showed significantly increased plasma urea concentration compared with sham-fasted animals. Whether this increased urea is a result of reduced clearance, increased proteolysis, or increased production (arginase) remains to be investigated. Kidney function was significantly better in rats supplemented with flavonoids than in control fasted rats as indicated by lowered plasma creatinine and urea concentration (Figure 4A and 4B, respectively).

Addition of the flavonoid mixture protected the intestine from injury; this is seen by the significantly increased apoptosis level in preoperatively fed animals, whereas the flavonoid-fed animals showed apoptosis levels comparable to healthy control intestines. There are many factors influencing intestinal apoptosis levels; for instance, hampering gut blood flow or increased ROS and reactive nitrogen species (RNS). In this model, oxidative stress expressed as MDA concentration was more significantly lowered by addition of flavonoids to the preoperative feeding. This decrease in oxidative stress may indicate that at least part of the decreased apoptosis may be due to lowered oxidative stress.

The obtained data suggest that the flavonoid mixture used in this study has an additive protective effect over that seen with feeding alone. The flavonoid mixture even appears to correct a phenomenon of preoperative feeding that could be interpreted as negative, namely, the increased total body oxidative stress. This increase is evident from the plasma MDA concentration. The addition of the flavonoid mixture resulted in significantly lowered MDA concentration to a level that is similar to that in sham-treated animals.

In conclusion, these data strongly suggests that the addition of selected flavonoids to preoperatively fed animals provides an effective protection of kidney function and reduces intestinal apoptosis in a rat IR injury model, to a higher extent than seen in normal preoperatively fed animals. This implies that preoperative intake of nutrition additionally supplemented with selected XO cascade inhibitors is a more efficient manner to prepare a rat for intestinal IR injury than feeding alone. The question remains whether this rat data may have the same implications for humans undergoing operations.

ACKNOWLEDGMENTS

Financial support for this study was provided by BTS grant BTS98020. We thank Nico van Munster and Rob Erik Blank for assistance on MDA measurement.

REFERENCES

1. Darlington DN, Jones RO, Marzella L, Gann DS. Changes in regional vascular resistance and blood volume after hemorrhage in fed and fasted awake rats. JAppl Physiol. 1995;78:2025-2032.

2. Esahili AH, Boija PO, Ljungqvist O, Rubio C, Ware J. Twentyfour hour fasting increases endotoxin lethality in the rat. Eur J Surf·. 1991;157:89-95.

3. Longarela A, Olarra J, Suarez L, Garcia de Lorenzo A. [Metabolic response to stress: can we control it?]. Nutr Hosp. 2000;15: 275-279.

4. Alibegovic A, Ljungqvist O. Pretreatment with glucose infusion prevents fatal outcome after hemorrhage in food deprived rats. C(Vc- Shock. 1993;39:l-6.

5. Ma SW, Foster DO. Starvation-induced changes in metabolic rate, blood flow, and regional energy expenditure in rats. Can J Phyniol Pharmacol. 1986;64:1252-1258.

6. Braga M, Gianotti L, Gentilini O, Parisi V, Salis C, Di Carlo V. Early postoperative enterai nutrition improves gut oxygénation and reduces costs compared with total parenteral nutrition. Crit Can- Med. 2001;29:242-248.

7. Crowe PJ, Dennison A, Royle GT. The effect of pre-operative glucose loading on postoperative nitrogen metabolism. Br J Surg. 1984:71:635-637.

8. Hessov I, Ljungqvist O. Perioperative oral nutrition. Curr Opin CHn Nutr Metab Care. 1998;l:29-33.

9. Meijerink WJ, von Meyenfeldt MF, Rouflart MM, Soeters PB. Efficacy of perioperative nutritional support. Lancet. 1992;340: 187-188.

10. Moore FA, Moore EE, Jones TN, McCroskey BL, Peterson VM. TEN versus TPN following major abdominal trauma-reduced septic morbidity. J Trauma. 1989;29:916-923.

11. Moore EE, Jones TN. Benefits of immediate jejunostomy feeding after major abdominal trauma: a prospective, randomized study. J Trauma. 1986;26:874-881.

12. Moore EE, Jones TN. Nutritional assessment and preliminary report on early support of the trauma patient. J Am Coll Nutr. 1983;2:45-54.

13. Moore FA, Feliciano DV, Andrassy RJ, et al. Early enterai feeding, compared with parenteral, reduces postoperative septic complications: the results of a meta-analysis. Ann Surg. 1992; 216:172-183.

14. Wilmore DW. Postoperative protein sparing. World J Surg. 1999;23:545-552.

15. van Hoorn DE, Boelens PG, van Middelaar-Voskuilen MC, et al. Pre-operative feeding preserves heart function and decreases oxidative injury in rats. Nutrition. 2005;21:885-886.

16. Jaeschke H. Xanthine oxidase-induced oxidant stress during hepatic ischemia-reperfusion: are we coming full circle after 20 years? Hepatology. 2002;36:761-763.

17. Kooij A, Schiller HJ, Schijns M, Van Noorden CJ, Frederiks WM. Conversion of xanthine dehydrogenase into xanthine oxidase in rat liver and plasma at the onset of reperfusion after ischemia. Hepatology. 1994;19:1488-1495.

18. Adkins WK, Taylor AE. Role of xanthine oxidase and neutrophils in ischemia-reperfusion injury in rabbit lung. J Appl Physiol. 1990;69:2012-2018.

19. Borges F, Fernandes E, Roleira F. Progress towards the discovery of xanthine oxidase inhibitors. Curr Med Chem. 2002;9:195217.

20. Gute DC, Ishida T, Yarimizu K, Korthuis RJ. Inflammatory responses to ischemia and reperfusion in skeletal muscle. MoI Cell Biochem. 1998;179:169-187.

21. Brealey D, Brand M, Hargreaves I, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet. 2002;360:219-223.

22. Oldham KM, Bowen PE. Oxidative stress in critical care: is antioxidant supplementation beneficial? J Am Diet Assoc. 1998; 98:1001-1008.

23. Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K, van Leeuwen PA. Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr. 2001;74:418-425.

24. van Hoorn DE, Nijveldt RJ, Van Leeuwen PA, et al. Accurate prediction of xanthine oxidase inhibition based on the structure of flavonoids. Eur J Pharmacol. 2002;451:111-118.

25. van Jaarsveld H, Kuyl JM, Schulenburg DH, Wiid NM. Effect of flavonoids on the outcome of myocardial mitochondrial ischemia/reperfusion injury. Res Commun Mol Pathol Pharmacol. 1996;91:65-75.

26. Sanhueza J, Valdes J, Campos R, Garrido A, Valenzuela A. Changes in the xanthine dehydrogenase/xanthine oxidase ratio in the rat kidney subjected to ischemia-reperfusion stress: preventive effect of some flavonoids. Res Commun Chern Pathol Pharmacol. 1992;78:211-218.

27. Shoskes DA. Effect of bioflavonoids quercetin and curcumin on ischémie renal injury: a new class of renoprotective agents. Transplantation. 1998;66:147-152.

28. Miyake Y, Yamamoto K, Tsujihara N, Osawa T. Protective effects of lemon flavonoids on oxidative stress in diabetic rats. Lipidx. 1998:33:689-695.

29. Liang YC, Huang YT, Tsai SH, Lin-Shiau SY, Chen CF, Lin JK. Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis. 1999;20:1945-1952.

30. Kirn HK, Cheon BS, Kirn YH, Kirn SY, Kirn HP. Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationships. Biochem Pharmacol. 1999;58:759-765.

31. Friesenecker B, Tsai AG, Intaglietta M. Cellular basis of inflammation, edema and the activity of Daflon 500 mg. hit J Microcirc ClinExp. 1995;15:17-21.

32. Lindahl M, Tagesson C. Flavonoids as phospholipase A2 inhibitors: importance of their structure for selective inhibition of group II phospholipase A2. Inflammation. 1997;21:347-356.

33. Middleton E Jr. Effect of plant flavonoids on immune and inflammatory cell function. Adv Exp Med Biol. 1998;439:175-182.

34. Hoorn van EC, Middelaar-Voskuilen van MC, Limpt van CJ, et al. Preoperative supplementation with a carbohydrate mixture decreases organ dysfunction-associated risk factors. Clin Nutr. 2005;24:114-123.

35. Cao G, Alessio HM, Cutler RG. Oxygen-radical absorbance capacity assay for antioxidants. Free Radie Biol Med. 1993; 14: 303-311.

36. Cargnoni A, Ceconi C, Curello S, Benigno M, de Jong JW, Ferrari R. Relation between energy metabolism, glycolysis, noradrenaline release and duration of ischemia. MoI Cell Biochem. 1996; 160-161:187-194.

37. Argaud L, Ovize M. [Myocardial metabolism abnormalities during ischemia and reperfusionl. Arch Mal Coeur Vaiss. 2000;93: 87-90.

38. Das DK, Maulik N. Bioenergetics, ischémie contracture and reperfusion injury. EXS. 1996;76:155-173.

39. Van Way CW, Dhar A, Reddy R, Evans L, Wogahn B, Helling TS. Changes in adenine nucleotides during hemorrhagic shock and reperfusion. J Surg Res. 1996;66:159-166.

40. Iwai T, Tanonaka K, Inoue R, et al. Sodium accumulation during ischemia induces mitochondrial damage in perfused rat hearts. Cardiovasc Res. 2002;55:141-149.

41. Schafer C, Ladilov Y, Inserte J, et al. Role of the reverse mode of the Na+/Ca2+ exchanger in reoxygenation-induced cardiomyocyte injury. Cardiovasc Res. 2001;51:241-250.

42. Xiao XH, Alien DG. Activity of the Na( + )/H( + ) exchanger is critical to reperfusion damage and preconditioning in the isolated rat heart. Cardiovasc Res. 2000;48:244-253.

43. Crenesse D, Hugues M, Ferre C, et al. Inhibition of calcium influx during hypoxia/reoxygenation in primary cultured rat hepatocytes. Pharmacology. 1999;58:160-170.

44. Scholz W, Albus U, Linz W, Martorana P, Lang HJ, Scholkens BA. Effects of Na+/H+ exchange inhibitors in cardiac ischemia. J Mol Cell Cardiol. 1992;24:731-739.

45. Veitch K, Hombroeckx A, Caucheteux D, Pouleur H, Hue L. Global ischaemia induces a biphasic response of the mitochondrial respiratory chain. Anoxie pré-perfusion protects against ischaemic damage. Biochem J. 1992;281:709-715.

46. Jassem W, Fuggle SV, ReIa M, Koo DD, Heaton ND. The role of mitochondria in ischemia/reperfusion injury. Transplantation. 2002;73:493-499.

47. Vega VL, Mardones L, Maldonado M, et al. Xanthine oxidase released from reperfused hind limbs mediate Kupffer cell activation, neutrophil sequestration, and hepatic oxidative stress in rats subjected to tourniquet shock. Shock. 2000;14:565-571.

49. Granger DN, Rutili G, McCord JM. Superoxide radicals in feline intestinal ischemia. Gastroenterology. 1981;81:22-29.

50. Saksela M, Lapatto R, Raivio KO. Xanthine oxidoreductase gene expression and enzyme activity in developing human tissues. BiolNeonate. 1998;74:274-280.

51. Houston M, Estevez A, Chumley P, et al. Binding of xanthine oxidase to vascular endothelium: kinetic characterization and oxidative impairment of nitric oxide-dependent signaling. J Biol Chem. 1999;274:4985-4994.

52. Matsumura F, Yamaguchi Y, Goto M, et al. Xanthine oxidase inhibition attenuates Kupffer cell production of neutrophil chemoattractant following ischemia-reperfusion in rat liver. Hepatology. 1998;28:1578-1587.

53. Nielsen VG, Tan S, Weinbroum A, et al. Lung injury after hepatoenteric ischemia-reperfusion: role of xanthine oxidase. Am J Respir Crit Care Med. 1996;154:1364-1369.

54. Gelpi RJ, Morales C, Cohen MV, Downey JM. Xanthine oxidase contributes to preconditioning’s preservation of left ventricular developed pressure in isolated rat heart: developed pressure may not be an appropriate end-point for studies of preconditioning. Basic Res Cardiol. 2002;97:40-46.

55. Kakita T, Suzuki M, Takeuchi H, Unno M, Matsuno S. Significance of xanthine oxidase in the production of intracellular oxygen radicals in an ßç-vitro hypoxia-reoxygenation model. J Hepatobil Pancreat Surg. 2002;9:249-255.

56. Hamanaka H, Mizutani H, Nouchi N, Shimizu Y, Shimizu M. Allopurinol hypersensitivity syndrome: hypersensitivity to oxypurinol but not allopurinol. Clin Exp Dermatal. 1998;23:32-34.

57. Flynn WJ Jr, Hoover EL. Allopurinol plus standard resuscitation preserves hepatic blood flow and function following hemorrhagic shock. J Trauma. 1994;37:956-961.

58. Clancy RR, McGaurn SA, Goin JE, et al. Allopurinol neurocardiac protection trial in infants undergoing heart surgery using deep hypothermie circulatory arrest. Pediatrics. 2001;108:61-70.

59. Rhoden E, Teloken C, Lucas M, et al. Protective effect of allopurinol in the renal ischemia-reperfusion in uninephrectomized rats. Gen Pharmacol. 2000;35:189-193.

60. Erlund I, Silaste ML, Alfthan G, Rantala M, Kesaniemi YA, Aro A. Plasma concentrations of the flavonoids hesperetin, naringenin and quercetin in human subjects following their habitual diets, and diets high or low in fruit and vegetables. Eur J Clin Nutr. 2002;56:891-898.

61. Donovan JL, Crespy V, Manach C, et al. Catechin is metabolized by both the small intestine and liver of rats. J Nutr. 2001;131: 1753-1757.

62. Scalbert A, Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr. 2000;130:2073S-2085S.

Danny E. C. van Hoorn, PhD*; Robert J. Nijveldt, PhD[dagger]; Petra G. Boelens, MSc[dagger]; Zandrie Hofman*; Paul A. M. van Leeuwen, MSc, PhD[dagger]; and Klaske van Norren, PhD*

From *Numico Research, BMR, Wageningen, the Netherlands; and the [dagger]VU University Medical Center, Department of Surgery, Amsterdam, the Netherlands

Received for publication December 28, 2005.

Accepted for publication March 29, 2006.

Correspondence: Dr K. van Norren, Numico Research BV, PO Box 7005, 6704 PH Wageningen, The Netherlands. Electronic mail may be sent to Klaske.vanNorren@Numico-research.nl.

Copyright American Society for Parenteral and Enteral Nutrition Jul/Aug 2006

Provided by ProQuest Information and Learning Company. All rights Reserved